Evaluating the effects of genetic variants of DNA repair genes using cytogenetic mutagen sensitivity approaches

References

• Abdel-Rahman SZ, El-Zein RA. (2000). The 399Gln polymorphism in the DNA repair gene XRCC1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK. Cancer Lett 159:63–71.
   PubMed Web of Science ®Google Scholar
• Affatato AA, Wolfe KJ, Lopez MS, Hallberg C, Ammenheuser MM, Abdel-Rahman SZ. (2004). Effect of XPD/ERCC2 polymorphisms on chromosome aberration frequencies in smokers and on sensitivity to the mutagenic tobacco-specific nitrosamine NNK. Environ Mol Mutagen 44:65–73.
   PubMedGoogle Scholar
• Aka P, Mateuca R, Buchet JP, Thierens H, Kirsch-Volders M. (2004). Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res 556:169–181.
   PubMed Web of Science ®Google Scholar
• Angelini S, Kumar R, Carbone F, Bermejo JL, Maffei F, Cantelli-Forti G, Hemminki K, Hrelia P. (2008). Inherited susceptibility to bleomycin-induced micronuclei: Correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity. Mutat Res 638:90–97.
   PubMedGoogle Scholar
• Au WW, Bechtold WE, Whorton EB Jr, Legator MS. (1995a). Chromosome aberrations and response to γ-ray challenge in lymphocytes of workers exposed to 1,3-butadiene. Mutat Res 334:125–130.
   PubMed Web of Science ®Google Scholar
• Au WW, Giri AK, Ruchirawat M. (2010). Challenge assay: A functional biomarker for exposure-induced DNA repair deficiency and for risk of cancer. Int J Hyg Environ Health 213:32–39.
   PubMed Web of Science ®Google Scholar
• Au WW, Lane RG, Legator MS, Whorton EB, Wilkinson GS, Gabehart GJ. (1995b). Biomarker monitoring of a population residing near uranium mining activities. Environ Health Perspect 103:466–470.
   PubMed Web of Science ®Google Scholar
• Au WW, Salama SA. (2005). Use of biomarkers to elucidate genetic susceptibility to cancer. Environ Mol Mutagen 45:222–228.
   PubMed Web of Science ®Google Scholar
• Au WW, Salama SA, Sierra-Torres CH. (2003). Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111:1843–1850.
   PubMed Web of Science ®Google Scholar
• Au WW, Sierra-Torres CH, Cajas-Salazar N, Shipp BK, Legator MS. (1999). Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ Health Perspect 107:501–505.
   PubMed Web of Science ®Google Scholar
• Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, De Ridder L, Vral A. (2002). Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379–1385.
   PubMed Web of Science ®Google Scholar
• Baeyens A, Thierens H, Claes K, Poppe B, De Ridder L, Vral A. (2004). Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol 80:745–756.
   PubMed Web of Science ®Google Scholar
• Baeyens A, Van Den Broecke R, Makar A, Thierens H, De Ridder L, Vral A. (2005). Chromosomal radiosensitivity in breast cancer patients: Influence of age of onset of the disease. Oncol Rep 13:347–353.
   PubMed Web of Science ®Google Scholar
• Bau DT, Mau YC, Ding SL, Wu PE, Shen CY. (2007). DNA double-strand break repair capacity and risk of breast cancer. Carcinogenesis 28:1726–1730.
   PubMed Web of Science ®Google Scholar
• Berwick M, Vineis P. (2000). Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J Natl Cancer Inst 92:874–897.
   PubMed Web of Science ®Google Scholar
• Bonassi S, Hagmar L, Strömberg U, Montagud AH, Tinnerberg H, Forni A, Heikkilä P, Wanders S, Wilhardt P, Hansteen IL, Knudsen LE, Norppa H. (2000). Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 60:1619–1625.
   PubMed Web of Science ®Google Scholar
• Bonassi S, Znaor A, Norppa H, Hagmar L. (2004). Chromosomal aberrations and risk of cancer in humans: An epidemiologic perspective. Cytogenet Genome Res 104:376–382.
   PubMed Web of Science ®Google Scholar
• Bondy ML, Kyritsis AP, Gu J, de Andrade M, Cunningham J, Levin VA, Bruner JM, Wei Q. (1996). Mutagen sensitivity and risk of gliomas: A case-control analysis. Cancer Res 56:1484–1486.
   PubMed Web of Science ®Google Scholar
• Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM, Levin VA, Alfred Yung WK, Adatto P, Wei Q. (2001). Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553–1557.
   PubMed Web of Science ®Google Scholar
• Cazaux C. (2010). Genetic instability as a driver for oncogenesis. Bull Cancer 97:1241–1251.
   PubMedGoogle Scholar
• Shibata D. (2011). Mutation and epigenetic molecular clocks in cancer. Carcinogenesis 32:123–128.
   Google Scholar
• Chanvaivit S, Navasumrit P, Hunsonti P, Autrup H, Ruchirawat M. (2007). Exposure assessment of benzene in Thai workers, DNA-repair capacity and influence of genetic polymorphisms. Mutat Res 626:79–87.
   PubMed Web of Science ®Google Scholar
• Chao DL, Maley CC, Wu X, Farrow DC, Galipeau PC, Sanchez CA, Paulson TG, Rabinovitch PS, Reid BJ, Spitz MR, Vaughan TL. (2006). Mutagen sensitivity and neoplastic progression in patients with Barrett’s esophagus: A prospective analysis. Cancer Epidemiol Biomarkers Prev 15:1935–1940.
   PubMedGoogle Scholar
• Cheng J, Leng S, Dai Y, Huang C, Pan Z, Niu Y, Li B, Zheng Y. (2007). Association between nucleotide excision repair gene polymorphisms and chromosomal damage in coke-oven workers. Biomarkers 12:76–86.
   PubMed Web of Science ®Google Scholar
• Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. (1998). Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 7:465–468.
   PubMed Web of Science ®Google Scholar
• Cloos J, Spitz MR, Schantz SP, Hsu TC, Zhang ZF, Tobi H, Braakhuis BJ, Snow GB. (1996). Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst 88:530–535.
   PubMed Web of Science ®Google Scholar
• Cloutier JF, Drouin R, Weinfeld M, O’Connor TR, Castonguay A. (2001). Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA. J Mol Biol 313:539–557.
   PubMedGoogle Scholar
• Cornetta T, Padua L, Testa A, Ievoli E, Festa F, Tranfo G, Baccelliere L, Cozzi R. (2008). Molecular biomonitoring of a population of nurses handling antineoplastic drugs. Mutat Res 638:75–82.
   PubMed Web of Science ®Google Scholar
• Decordier I, De Bont K, De Bock K, Mateuca R, Roelants M, Ciardelli R, Haumont D, Knudsen LE, Kirsch-Volders M. (2007). Genetic susceptibility of newborn daughters to oxidative stress. Toxicol Lett 172:68–84.
   PubMed Web of Science ®Google Scholar
• Decordier I, Loock KV, Kirsch-Volders M. (2010). Phenotyping for DNA repair capacity. Mutat Res 705:107–129.
   PubMed Web of Science ®Google Scholar
• Decordier I, Mateuca R, Kirsch-Volders M. (2011). Micronucleus assay and labeling of centromeres with FISH technique. Methods Mol Biol 691:115–136.
   PubMedGoogle Scholar
• El-Zein R, Etzel CJ, Lopez MS, Gu Y, Spitz MR, Strom SS. (2006a). Human sensitivity to PhIP: A novel marker for prostate cancer risk. Mutat Res 601:1–10.
   PubMedGoogle Scholar
• El-Zein R, Vral A, Etzel CJ. (2011). Cytokinesis-blocked micronucleus assay and cancer risk assessment. Mutagenesis 26:101–106.
   PubMed Web of Science ®Google Scholar
• El-Zein RA, Fenech M, Lopez MS, Spitz MR, Etzel CJ. (2008). Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev 17:1111–1119.
   PubMed Web of Science ®Google Scholar
• El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. (2006b). Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66:6449–6456.
   PubMed Web of Science ®Google Scholar
• El-Zein R, Shaw P, Tyring SK, Au WW. (1995). Chromosomal radiosensitivity of lymphocytes from skin cancer-prone patients. Mutat Res 335:143–149.
   PubMedGoogle Scholar
• Fenech M. (2000). The in vitro micronucleus technique. Mutat Res 455:81–95.
   PubMed Web of Science ®Google Scholar
• Fenech M. (2007). Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084–1104.
   PubMed Web of Science ®Google Scholar
• Fu YP, Yu JC, Cheng TC, Lou MA, Hsu GC, Wu CY, Chen ST, Wu HS, Wu PE, Shen CY. (2003). Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: A multigenic study on cancer susceptibility. Cancer Res 63:2440–2446.
   PubMed Web of Science ®Google Scholar
• Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. (2002). The structure of haplotype blocks in the human genome. Science 296:2225–2229.
   PubMed Web of Science ®Google Scholar
• Godderis L, Aka P, Mateuca R, Kirsch-Volders M, Lison D, Veulemans H. (2006). Dose-dependent influence of genetic polymorphisms on DNA damage induced by styrene oxide, ethylene oxide and γ-radiation. Toxicology 219:220–229.
   PubMed Web of Science ®Google Scholar
• Godderis L, De Boeck M, Haufroid V, Emmery M, Mateuca R, Gardinal S, Kirsch-Volders M, Veulemans H, Lison D. (2004). Influence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers. Environ Mol Mutagen 44:293–303.
   PubMed Web of Science ®Google Scholar
• Goode EL, Ulrich CM, Potter JD. (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11:1513–1530.
   PubMed Web of Science ®Google Scholar
• Grossman L. (1997). Epidemiology of ultraviolet-DNA repair capacity and human cancer. Environ Health Perspect 105 Suppl 4:927–930.
   PubMedGoogle Scholar
• Hanawalt PC. (1995). DNA repair comes of age. Mutat Res 336:101–113.
   PubMed Web of Science ®Google Scholar
• Hecht SS. (1998). Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 11:559–603.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Xu G, Angelini S, Snellman E, Jansen CT, Lambert B, Hou SM. (2001). XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carcinogenesis 22:1185–1188.
   PubMed Web of Science ®Google Scholar
• Hill CE, Affatato AA, Wolfe KJ, Lopez MS, Hallberg CK, Canistro D, Abdel-Rahman SZ. (2005b). Gender differences in genetic damage induced by the tobacco-specific nitrosamine NNK and the influence of the Thr241Met polymorphism in the XRCC3 gene. Environ Mol Mutagen 46:22–29.
   PubMedGoogle Scholar
• Hill CE, Wickliffe JK, Wolfe KJ, Kinslow CJ, Lopez MS, Abdel-Rahman SZ. (2005a). The L84F and the I143V polymorphisms in the O6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK. Pharmacogenet Genomics 15:571–578.
   PubMed Web of Science ®Google Scholar
• Hiom K. (2010). Coping with DNA double strand breaks. DNA Repair (Amst) 9:1256–1263.
   PubMed Web of Science ®Google Scholar
• Hsieh P. (2001). Molecular mechanisms of DNA mismatch repair. Mutat Res 486:71–87.
   PubMed Web of Science ®Google Scholar
• Hsu TC. (1983). Genetic instability in the human population: A working hypothesis. Hereditas 98:1–9.
   PubMedGoogle Scholar
• Hsu TC, Johnston DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Winn RJ, Shirley L, Furlong C. (1989). Sensitivity to genotoxic effects of bleomycin in humans: Possible relationship to environmental carcinogenesis. Int J Cancer 43:403–409.
   PubMed Web of Science ®Google Scholar
• Hsu TC, Spitz MR, Schantz SP. (1991). Mutagen sensitivity: A biological marker of cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1:83–89.
   PubMed Web of Science ®Google Scholar
• Hulla JE, Miller MS, Taylor JA, Hein DW, Furlong CE, Omiecinski CJ, Kunkel TA. (1999). Symposium overview: The role of genetic polymorphism and repair deficiencies in environmental disease. Toxicol Sci 47:135–143.
   PubMedGoogle Scholar
• Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. (2009). Silent (synonymous) SNPs: Should we care about them? Methods Mol Biol 578:23–39.
   PubMedGoogle Scholar
• Ishikawa T, Ide F, Qin X, Zhang S, Takahashi Y, Sekiguchi M, Tanaka K, Nakatsuru Y. (2001). Importance of DNA repair in carcinogenesis: Evidence from transgenic and gene targeting studies. Mutat Res 477:41–49.
   PubMedGoogle Scholar
• Johnson AD, Wang D, Sadee W. (2005). Polymorphisms affecting gene regulation and mRNA processing: Broad implications for pharmacogenetics. Pharmacol Ther 106:19–38.
   PubMed Web of Science ®Google Scholar
• Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. (2007). A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science 315:525–528.
   PubMed Web of Science ®Google Scholar
• Kimura M, Umegaki K, Higuchi M, Thomas P, Fenech M. (2004). Methylenetetrahydrofolate reductase C677T polymorphism, folic acid and riboflavin are important determinants of genome stability in cultured human lymphocytes. J Nutr 134:48–56.
   PubMed Web of Science ®Google Scholar
• Kinslow CJ, El-Zein RA, Hill CE, Wickliffe JK, Abdel-Rahman SZ. (2008). Single nucleotide polymorphisms 5’ upstream the coding region of the NEIL2 gene influence gene transcription levels and alter levels of genetic damage. Genes Chromosomes Cancer 47:923–932.
   PubMedGoogle Scholar
• Kirsch-Volders M, Elhajouji A, Cundari E, Van Hummelen P. (1997). The in vitro micronucleus test: A multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat Res 392:19–30.
   PubMed Web of Science ®Google Scholar
• Kirsch-Volders M, Vanhauwaert A, De Boeck M, Decordier I. (2002). Importance of detecting numerical versus structural chromosome aberrations. Mutat Res 504:137–148.
   PubMed Web of Science ®Google Scholar
• Kolodner RD, Marsischky GT. (1999). Eukaryotic DNA mismatch repair. Curr Opin Genet Dev 9:89–96.
   PubMed Web of Science ®Google Scholar
• Leng S, Stidley CA, Bernauer AM, Picchi MA, Sheng X, Frasco MA, Van Den Berg D, Gilliland FD, Crowell RE, Belinsky SA. (2008). Haplotypes of DNMT1 and DNMT3B are associated with mutagen sensitivity induced by benzo[a]pyrene diol epoxide among smokers. Carcinogenesis 29:1380–1385.
   PubMedGoogle Scholar
• Lin J, Swan GE, Shields PG, Benowitz NL, Gu J, Amos CI, de Andrade M, Spitz MR, Wu X. (2007). Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: Genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 16:2065–2071.
   PubMed Web of Science ®Google Scholar
• Liu Y, Shete S, Wang LE, El-Zein R, Etzel CJ, Liang FW, Armstrong G, Tsavachidis S, Gilbert MR, Aldape KD, Xing J, Wu X, Wei Q, Bondy ML. (2010a). Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk. Carcinogenesis 31:1762–1769.
   PubMedGoogle Scholar
• Liu N, Guan W, Meng H, Cui T, Li Z, Cheng J, Xiao J, Wang X, Li B. (2010b). Association of XRCC4 polymorphisms and chromosomal damage levels in 1,3-butadiene workers. Wei Sheng Yan Jiu 39:407–411.
   PubMedGoogle Scholar
• López de Mesa R, López de Ceráin Salsamendi A, Sierrasesúmaga Ariznabarreta L, Calasanz Abínzano MJ, Patiño-García A. (2002). Measurement and analysis of the chemotherapy-induced genetic instability in pediatric cancer patients. Mutagenesis 17:171–175.
   PubMedGoogle Scholar
• Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q. (2007). 172G>T variant in the 5’ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 28:988–994.
   PubMedGoogle Scholar
• Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA. (2000). XPD polymorphisms: Effects on DNA repair proficiency. Carcinogenesis 21:551–555.
   PubMed Web of Science ®Google Scholar
• Mahaney BL, Meek K, Lees-Miller SP. (2009). Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 417:639–650.
   PubMed Web of Science ®Google Scholar
• Maher VM, Ouellette LM, Curren RD, McCormick JJ. (1976). Frequency of ultraviolet light-induced mutations is higher in xeroderma pigmentosum variant cells than in normal human cells. Nature 261:593–595.
   PubMed Web of Science ®Google Scholar
• Marin M. (2008). Folding at the rhythm of the rare codon beat. Biotechnol J 3:1047–1057.
   PubMedGoogle Scholar
• Mateuca R, Aka PV, De Boeck M, Hauspie R, Kirsch-Volders M, Lison D. (2005). Influence of hOGG1, XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts. Toxicol Lett 156:277–288.
   PubMed Web of Science ®Google Scholar
• Mateuca R, Lombaert N, Aka PV, Decordier I, Kirsch-Volders M. (2006). Chromosomal changes: Induction, detection methods and applicability in human biomonitoring. Biochimie 88:1515–1531.
   PubMed Web of Science ®Google Scholar
• Mateuca RA, Roelants M, Iarmarcovai G, Aka PV, Godderis L, Tremp A, Bonassi S, Fenech M, Bergé-Lefranc JL, Kirsch-Volders M. (2008). hOGG1(326), XRCC1(399) and XRCC3(241) polymorphisms influence micronucleus frequencies in human lymphocytes in vivo. Mutagenesis 23:35–41.
   PubMed Web of Science ®Google Scholar
• Navasumrit P, Arayasiri M, Hiang OM, Leechawengwongs M, Promvijit J, Choonvisase S, Chantchaemsai S, Nakngam N, Mahidol C, Ruchirawat M. (2008). Potential health effects of exposure to carcinogenic compounds in incense smoke in temple workers. Chem Biol Interact 173:19–31.
   PubMed Web of Science ®Google Scholar
• Norppa H, Bonassi S, Hansteen IL, Hagmar L, Strömberg U, Rössner P, Boffetta P, Lindholm C, Gundy S, Lazutka J, Cebulska-Wasilewska A, Fabiánová E, Srám RJ, Knudsen LE, Barale R, Fucic A. (2006). Chromosomal aberrations and SCEs as biomarkers of cancer risk. Mutat Res 600:37–45.
   PubMed Web of Science ®Google Scholar
• Oberheitmann B, Frentzel-Beyme R, Hoffmann W. (2001). An application of the challenge assay in boat builders exposed to low levels of styrene–a feasibility study of a possible biomarker for acquired susceptibility. Int J Hyg Environ Health 204:23–29.
   PubMed Web of Science ®Google Scholar
• Oesch F, Aulmann W, Platt KL, Doerjer G. (1987). Individual differences in DNA repair capacities in man. Arch Toxicol Suppl 10:172–179.
   PubMedGoogle Scholar
• Paterson MC, Smith PJ. (1979). Ataxia telangiectasia: An inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet 13:291–318.
   PubMed Web of Science ®Google Scholar
• Payne S. (2001). Smoke like a man, die like a man?: A review of the relationship between gender, sex and lung cancer. Soc Sci Med 53:1067–1080.
   PubMed Web of Science ®Google Scholar
• Roberts SA, Spreadborough AR, Bulman B, Barber JB, Evans DG, Scott D. (1999). Heritability of cellular radiosensitivity: A marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 65:784–794.
   PubMed Web of Science ®Google Scholar
• Rondelli CM, El-Zein RA, Wickliffe JK, Etzel CJ, Abdel-Rahman SZ. (2010). A comprehensive haplotype analysis of the XPC genomic sequence reveals a cluster of genetic variants associated with sensitivity to tobacco-smoke mutagens. Toxicol Sci 115:41–50.
   PubMedGoogle Scholar
• Ronen A, Glickman BW. (2001). Human DNA repair genes. Environ Mol Mutagen 37:241–283.
   PubMed Web of Science ®Google Scholar
• Rothfuss A, Schütz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G. (2000). Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390–394.
   PubMed Web of Science ®Google Scholar
• Scott D, Barber JB, Levine EL, Burrill W, Roberts SA. (1998). Radiation-induced micronucleus induction in lymphocytes identifies a high frequency of radiosensitive cases among breast cancer patients: A test for predisposition? Br J Cancer 77:614–620.
   PubMed Web of Science ®Google Scholar
• Setlow RB. (1985). Variation in DNA repair among people. In: Castellani E, ed. Epidemiology and quantitation of environmental risk in humans for radiation and other agents. New York: Plenum Press, pp. 205–212.
   Google Scholar
• Shen H, Spitz MR, Qiao Y, Guo Z, Wang LE, Bosken CH, Amos CI, Wei Q. (2003). Smoking, DNA repair capacity and risk of nonsmall cell lung cancer. Int J Cancer 107:84–88.
   PubMed Web of Science ®Google Scholar
• Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q. (2002). A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Int J Cancer 99:869–872.
   PubMed Web of Science ®Google Scholar
• Shen MR, Jones IM, Mohrenweiser H. (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604–608.
   PubMed Web of Science ®Google Scholar
• Sigurdson AJ, Jones IM, Wei Q, Wu X, Spitz MR, Stram DA, Gross MD, Huang WY, Wang LE, Gu J, Thomas CB, Reding DJ, Hayes RB, Caporaso NE. (2011). Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Carcinogenesis 32:69–73.
   PubMed Web of Science ®Google Scholar
• Siller E, DeZwaan DC, Anderson JF, Freeman BC, Barral JM. (2010). Slowing bacterial translation speed enhances eukaryotic protein folding efficiency. J Mol Biol 396:1310–1318.
   PubMedGoogle Scholar
• Smerhovsky Z, Landa K, Rössner P, Brabec M, Zudova Z, Hola N, Pokorna Z, Mareckova J, Hurychova D. (2001). Risk of cancer in an occupationally exposed cohort with increased level of chromosomal aberrations. Environ Health Perspect 109:41–45.
   PubMed Web of Science ®Google Scholar
• Spitz MR, Bondy ML. (1993). Genetic susceptibility to cancer. Cancer 72:991–995.
   PubMed Web of Science ®Google Scholar
• Spitz MR, Hsu TC, Wu X, Fueger JJ, Amos CI, Roth JA. (1995). Mutagen sensitivity as a biological marker of lung cancer risk in African Americans. Cancer Epidemiol Biomarkers Prev 4:99–103.
   PubMed Web of Science ®Google Scholar
• Spitz MR, McPherson RS, Jiang H, Hsu TC, Trizna Z, Lee JJ, Lippman SM, Khuri FR, Steffen-Batey L, Chamberlain RM, Schantz SP, Hong WK. (1997). Correlates of mutagen sensitivity in patients with upper aerodigestive tract cancer. Cancer Epidemiol Biomarkers Prev 6:687–692.
   PubMedGoogle Scholar
• Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q. (2001). Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 61:1354–1357.
   PubMed Web of Science ®Google Scholar
• Stern MC, Umbach DM, Lunn RM, Taylor JA. (2002). DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 11:939–943.
   PubMed Web of Science ®Google Scholar
• Takano K, Nakamura T, Sekiguchi M. (1991). Roles of two types of O6-methylguanine-DNA methyltransferases in DNA repair. Mutat Res 254:37–44.
   PubMedGoogle Scholar
• Tuimala J, Szekely G, Gundy S, Hirvonen A, Norppa H. (2002). Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: Role in mutagen sensitivity. Carcinogenesis 23:1003–1008.
   PubMed Web of Science ®Google Scholar
• Tuntawiroon J, Mahidol C, Navasumrit P, Autrup H, Ruchirawat M. (2007). Increased health risk in Bangkok children exposed to polycyclic aromatic hydrocarbons from traffic-related sources. Carcinogenesis 28:816–822.
   PubMed Web of Science ®Google Scholar
• Tutt A, Ashworth A. (2002). The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med 8:571–576.
   PubMed Web of Science ®Google Scholar
• Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q. (2005a). In vitro sensitivity to ultraviolet B light and skin cancer risk: A case-control analysis. J Natl Cancer Inst 97:1822–1831.
   PubMedGoogle Scholar
• Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. (2005b). Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics 15:693–704.
   PubMed Web of Science ®Google Scholar
• Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X. (2003a). From genotype to phenotype: Correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2:901–908.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liang D, Spitz MR, Zhang K, Dong Q, Amos CI, Wu X. (2003b). XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer 98:1701–1706.
   PubMedGoogle Scholar
• Wei Q, Cheng L, Hong WK, Spitz MR. (1996a). Reduced DNA repair capacity in lung cancer patients. Cancer Res 56:4103–4107.
   PubMed Web of Science ®Google Scholar
• Wei Q, Gu J, Cheng L, Bondy ML, Jiang H, Hong WK, Spitz MR. (1996b). Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res 56:3975–3979.
   PubMed Web of Science ®Google Scholar
• Willems P, Claes K, Baeyens A, Vandersickel V, Werbrouck J, De Ruyck K, Poppe B, Van Den Broecke R, Makar A, Marras E, Perletti G, Thierens H, Vral A. (2008). Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 47:137–148.
   PubMed Web of Science ®Google Scholar
• Willems P, De Ruyck K, Van Den Broecke R, Makar A, Perletti G, Thierens H, Vral A. (2009). A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. J Cancer Res Clin Oncol 135:1159–1168.
   PubMedGoogle Scholar
• Wolfe KJ, Wickliffe JK, Hill CE, Paolini M, Ammenheuser MM, Abdel-Rahman SZ. (2007). Single nucleotide polymorphisms of the DNA repair gene XPD/ERCC2 alter mRNA expression. Pharmacogenet Genomics 17:897–905.
   PubMed Web of Science ®Google Scholar
• Wongvijitsuk S, Navasumrit P, Vattanasit U, Parnlob V, Ruchirawat M. (2011). Low level occupational exposure to styrene: Its effects on DNA damage and DNA repair. Int J Hyg Environ Health 214:127–137.
   PubMed Web of Science ®Google Scholar
• Wu X, Gu J, Spitz MR. (2007a). Mutagen sensitivity: A genetic predisposition factor for cancer. Cancer Res 67:3493–3495.
   PubMed Web of Science ®Google Scholar
• Wu X, Lin J, Etzel CJ, Dong Q, Gorlova OY, Zhang Q, Amos CI, Spitz MR. (2007b). Interplay between mutagen sensitivity and epidemiological factors in modulatinglung cancer risk. Int J Cancer 120:2687–2695.
   PubMedGoogle Scholar
• Wu X, Spitz MR, Amos CI, Lin J, Shao L, Gu J, de Andrade M, Benowitz NL, Shields PG, Swan GE. (2006). Mutagen sensitivity has high heritability: Evidence from a twin study. Cancer Res 66:5993–5996.
   PubMedGoogle Scholar
• Wu X, Yu H, Amos CI, Hong WK, Spitz MR. (2000). Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. Growth Horm IGF Res 10 Suppl A:S26–S27.
   Google Scholar
• Zhang J, Powell SN. (2005). The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 3:531–539.
   PubMedGoogle Scholar